Late Breaking Trials

WEDNESDAY,
SEPTEMBER 23

THURSDAY,
SEPTEMBER 24

FRIDAY,
SEPTEMBER 25

11:00 am

SPIRIT IV:
A Prospective Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents
Lecturer: Gregg W. Stone

11:00 am

CURRENT-PCI OASIS 7: A Prospective, Randomized, Placebo-Controlled Trial of High- vs. Standard-Dose Clopidogrel and High- vs. Low-Dose Aspirin in Patients Undergoing PCI for ACS
Lecturer: Shamir R. Mehta

11:00 am

SYMPLICITY I: One-Year Results Following Sympathetic Renal Denervation in Refractory Hypertension
Lecturer: Henry Krum

11:15 am

COMPARE: A Prospective Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents
Lecturer: Peter C. Smits

11:15 am

COGENT: A Prospective, Randomized, Placebo-Controlled Trial of Omeprazole in Patients Receiving Aspirin and Clopidogrel
Lecturer: Deepak L. Bhatt

11:15 am

DEBATER: A Prospective Randomized Trial of Drug-Eluting vs. Bare-Metal Stents With or Without Abciximab in STEMI
Lecturer: Rolf Michels

11:30 am

ISAR-DESIRE 2: A Prospective Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents for Treatment of Sirolimus-Eluting Stent Restenosis
Lecturer: Robert A. Byrne

11:30 am

CHARISMA GENOMICS SUBSTUDY: Evaluation of the CYP2C19 Polymorphism in a Prospective, Randomized, Placebo-Controlled Trial of Chronic Clopidogrel Use for Primary and Secondary Prevention
Lecturer: Deepak L. Bhatt

11:30 am

HORIZONS AMI: Two-Year Follow-up from a Prospective Randomized Trial of Heparin Plus Glycoprotein IIb/IIIa Inhibitors vs. Bivalirudin and Paclitaxel-Eluting vs. Bare-Metal Stents in STEMI
Lecturer: Gregg W. Stone

11:45 am

SIRTAX-LATE: Five-Year Clinical and Angiographic Follow-up from a Prospective Randomized Trial of Paclitaxel-Eluting and Sirolimus-Eluting Stents
Lecturer: Lorenz Räber

11:45 am

TRITON-TIMI 38 ECONOMIC SUBSTUDY: Cost-Effectiveness of Prasugrel vs. Clopidogrel from a Prospective Randomized Trial of Patients with ACS Undergoing PCI
Lecturer: David J. Cohen

11:45 am

BCIS-1: A Prospective Randomized Trial of Intra-Aortic Balloon Pump Counterpulsation in High-Risk Patients Undergoing PCI
Lecturer: Simon Redwood

12:00 pm

LEADERS: Two-Year Follow-up from a Prospective Randomized Trial of Biolimus A9-Eluting Stents with a Bioabsorbable Polymer vs. Sirolimus-Eluting Stents with a Durable Polymer
Lecturer: Klauss Volker

12:00 pm

PLATO INVASIVE: A Prospective, Randomized, Placebo-Controlled Trial of Ticagrelor vs. Clopidogrel in Patients with ACS Managed with an Invasive Strategy
Lecturer: Christopher P. Cannon

12:00 pm

NORDIC-BALTIC BIFURCATION STUDY III: A Prospective Randomized Trial of Side Branch Dilatation Strategies in Patients with Coronary Bifurcation Lesions Undergoing Treatment with a Single Stent
Lecturer: Matti Jaakko Niemela

12:15 pm

FAME: Two-Year Follow-up from a Prospective Randomized Trial of FFR-Guided vs. Angiography-Guided PCI in Patients with Multivessel Coronary Artery Disease
Lecturer: William F. Fearon

12:15 pm

PROSPECT: A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
Lecturer: Gregg W. Stone

12:15 pm

FAUST: A Prospective Randomized Trial of Ultrasound-Guided vs. Standard Femoral Arterial Access
Lecturer: Arnold Seto